Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02963831
Brief Title: A Phase 1/2 Study to Investigate the Safety, Biologic and Anti-tumor Activity of ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies

First Submitted : November 10, 2016
First Submitted that Met QC Criteria : November 10, 2016
First Posted : November 15, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 22, 2021
Last Update Posted : February 23, 2021